SCHEMBL793748

SCHEMBL793748

O=C(O)N1CCN(C(=O)COc2ccc(Cl)cc2)CC1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.75
HPGD P15428 2/20 0.75
MAPT P10636 1/20 0.75
RAB9A P51151 1/20 0.75
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
GPR183 P32249 1/20 0.72
ENPP2 Q13822 4/20 0.67
LMNA P02545 5/20 0.67
ALDH1A1 P00352 4/20 0.66
PKM P14618 2/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
KDM4E B2RXH2 1/20 0.63
HTT P42858 1/20 0.63
GAA P10253 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.61
ATF4 P18848 1/20 0.61
MAPK1 P28482 1/20 0.60
TSHR P16473 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27979662 0.94 POLB (0.84) POLBHPGDMAPTRAB9AMEN1
SCHEMBL19709040 0.87 HPGD (0.97) POLBHPGDMAPTRAB9AMEN1
SCHEMBL15134812 0.86 POLB (0.73) POLBHPGDMAPTRAB9AMEN1
SCHEMBL19705176 0.86 HPGD (1.00) POLBHPGDMAPTRAB9AMEN1
SCHEMBL5066354 0.84 LMNA (0.76) POLBHPGDMAPTRAB9AMEN1
SCHEMBL10282350 0.84 POLB (0.69) POLBHPGDMAPTRAB9AMEN1
SCHEMBL5061043 0.83 KMT2A (0.79) POLBHPGDMAPTRAB9AMEN1
SCHEMBL652845 0.83 POLB (0.73) POLBHPGDMAPTRAB9AMEN1
SCHEMBL170018 0.83 TPSAB1 (0.76) POLBHPGDMAPTRAB9AMEN1
SCHEMBL6783893 0.83 POLB (0.73) POLBHPGDMAPTRAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
EP-2575969-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-04-10 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed
EP-2405973-A2 THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2012-01-18 EP disclosed
WO-2011147753-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2011-12-01 WO disclosed
WO-2010103130-A2 NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2010-09-16 WO disclosed